Two drugmakers owe repayment to 340B covered entities, according to final audits posted this week by federal officials. American Health [...] …
Articles by : Rich Daly, Editor in Chief
Drug manufacturer Jazz Pharmaceuticals this week became the 25th drug manufacturer to impose conditions on 340B pricing involving delivery to contract [...] …
The California Senate recently cleared a bill to bar pharmacy benefit manager (PBM) alleged discrimination against 340B covered entities and [...] …
Republican House leaders were expected introduce—as soon as Sept. 8—and quickly advance a combined package of healthcare bills that includes [...] …
Eligible covered entities in Florida may enroll in the 340B program immediately rather than having to wait for the next [...] …
While federal regulators recently extended the comment period on a proposed lump sum repayment plan for hospitals Illegally underpaid for [...] …
Draft legislation that would exclude some generics from 340B and focus on penny pricing recently drew criticism from provider advocates. [...] …
Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023, unless spurred by [...] …
The congressional sponsor of legislation that would require hospitals and potentially other covered entities to publicly report their 340B revenue, [...] …
The boards of directors of health centers need to take on a bigger advocacy role in support of the 340B [...] …